FamiCord AG (FRA:V3V)

Market Cap	92.39M +29.9%
Revenue (ttm)	88.29M +9.5%
Net Income	-9.80M
EPS	-0.58
Shares Out	n/a
PE Ratio	n/a
Forward PE	71.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	22
Open	5.20
Previous Close	5.20
Day's Range	5.20 - 5.20
52-Week Range	3.64 - 7.65
Beta	n/a
RSI	43.61
Earnings Date	Apr 30, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the compa...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 771
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V3V

Financial Performance

In 2024, FamiCord AG's revenue was 82.18 million, an increase of 6.65% compared to the previous year's 77.06 million. Losses were -12.14 million, 550.7% more than in 2023.